Scarica l'app Stockscreener
14.53
2.22%
-0.33
Dopo l'orario di chiusura:
14.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AUPH Giù?
Forum
Previsione
Frazionamento azionario
Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie
Does Aurinia Pharmaceuticals Inc. offer margin of safetyJuly 2025 Big Picture & Safe Capital Investment Plans - mfd.ru
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Ritholtz Wealth Management Buys Shares of 84,515 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Aug Rallies: Will Aurinia Pharmaceuticals Inc benefit from government policyQuarterly Earnings Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - sharewise.com
Aurinia downgraded at RBC on risk-reward setup - MSN
How Investors May Respond To Aurinia Pharmaceuticals (AUPH) Expanding Autoimmune Pipeline And Deepening Otsuka Collaboration - Sahm
Trading the Move, Not the Narrative: (AUPH) Edition - Stock Traders Daily
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: 9.08% Potential Upside Amid Promising Biotech Innovations - DirectorsTalk Interviews
With 54% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance
How Aurinia Pharmaceuticals Inc. stock responds to policy changesWeekly Earnings Recap & Growth Focused Entry Point Reports - ulpravda.ru
Aurinia Pharmaceuticals (NASDAQ:AUPH) Share Price Passes Above 50-Day Moving AverageHere's Why - MarketBeat
How strong is Aurinia Pharmaceuticals Inc. stock balance sheetJuly 2025 Patterns & Growth Oriented Trade Recommendations - ulpravda.ru
Is Aurinia Pharmaceuticals Inc. stock a top pick in earnings seasonTrade Analysis Report & Precise Swing Trade Entry Alerts - ulpravda.ru
Earnings Report: Why Aurinia Pharmaceuticals Inc. (IKAP) stock stays resilientProfit Target & Weekly Top Gainers Trade List - Улправда
Is Aurinia Pharmaceuticals Inc. (IKAP) stock resilient in recession scenarios2025 Technical Patterns & Low Risk High Reward Ideas - Улправда
Why Aurinia Pharmaceuticals Inc. (IKAP) stock is listed among top recommendationsPortfolio Update Summary & Stock Timing and Entry Methods - Улправда
Why retail investors favor Aurinia Pharmaceuticals Inc. stockSupport Zone Identification & Free High Yield Growth Strategies - Улправда
Aruinia discloses FDA information request on Lupkynis amid top regulator’s exit - MSN
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Riding the Biotech Wave with 8.93% Potential Upside - DirectorsTalk Interviews
RBC Capital Downgrades Aurinia Pharmaceuticals (AUPH) - MSN
Aug Sectors: Why retail investors favor Aurinia Pharmaceuticals Inc. stockTrade Entry Report & Smart Swing Trading Alerts - moha.gov.vn
Aurinia Pharmaceuticals IncCommon Shares (NQ: AUPH - FinancialContent
(AUPH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Down 3.6%Here's Why - MarketBeat
Aurinia Pharmaceuticals (AUPH) Price Target Increased by 34.15% to 16.03 - MSN
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Is a Favorite Amongst Institutional Investors Who Own 54% - 富途牛牛
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Contender with a 4.89% Upside - DirectorsTalk Interviews
Spoke.comAurinia Pharmaceuticals IncCommon Shares (Nasdaq:AUPH) Stock Quote - FinancialContent
Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - AOL.com
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? - sharewise.com
Aurinia Pharmaceuticals (NASDAQ:AUPH) rises 3.1% this week, taking three-year gains to 292% - simplywall.st
Understanding the Setup: (AUPH) and Scalable Risk - Stock Traders Daily
How Aurinia Pharmaceuticals Inc. (IKAP) stock trades pre earningsDebt-to-Equity Ratio Analysis & Watch and Learn From Live Trades - bollywoodhelpline.com
Aurinia Pharmaceuticals stock hits 52-week high at 16.49 USD By Investing.com - Investing.com Australia
Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 12-Month HighHere's Why - MarketBeat
Aurinia Pharmaceuticals stock hits 52-week high at 16.49 USD - Investing.com
Why Aurinia Pharmaceuticals Inc. (IKAP) stock gets analyst attentionWeekly Market Outlook & Stock Timing and Entry Methods - Улправда
Chart Watch: Will Aurinia Pharmaceuticals Inc. stock pay special dividendsWall Street Watch & Free Risk Controlled Daily Trade Plans - Улправда
Will Aurinia Pharmaceuticals Inc. stock outperform international peersWeekly Stock Recap & Weekly High Return Stock Opportunities - Bölüm Sonu Canavarı
Is Aurinia Pharmaceuticals Inc. stock supported by innovation pipelineJuly 2025 Sector Moves & Community Verified Watchlist Alerts - DonanımHaber
Is Aurinia Pharmaceuticals Inc. (IKAP) stock undervalued after correction2025 Buyback Activity & Smart Swing Trading Techniques - DonanımHaber
Will Aurinia Pharmaceuticals Inc. stock benefit from automationPortfolio Value Report & Proven Capital Preservation Methods - DonanımHaber
Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms (NASDAQ:AUPH) - Seeking Alpha
Aurinia Pharmaceuticals Inc $AUPH Shares Purchased by Squarepoint Ops LLC - MarketBeat
Marex Group plc Buys Shares of 135,000 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
2.92%
2.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):